pubmed.ncbi.nlm.nih.gov

Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines - PubMed

Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines

A Jansson et al. J Virol. 1992 Jan.

Abstract

Eight of the nine viral antigens known to be expressed in in vitro Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cell lines are downregulated in EBV-carrying Burkitt lymphomas (BL). Only EBNA1 can be detected in BL biopsies and BL-derived cell lines that maintain the representative phenotype during culture in vitro (group I BL lines). This restricted pattern of viral gene expression is accompanied by extensive EBV DNA methylation and can be reversed by treatment with the demethylating agent 5-azacytidine. Transcription of the genes encoding the six transformation-associated EBNAs can be initiated from one of two promoters located in the BamHI C and W regions, respectively, of the virus genome. We show that discrete sites within the BamHI W enhancer region are methylated in the group I BL lines Rael, Cheptage, and Elijah and become unmethylated after 5-azacytidine treatment that induces the expression of EBNA2. Demethylation correlates with activation of transcription from the BamHI W promoter as determined by S1 protection analysis. Reporter plasmids in which the W enhancer sequences were linked to the chloramphenicol acetyltransferase gene were active in untreated Rael, Cheptage, and Elijah cells, demonstrating that all of the required transcription factors are present in group I BL cells. Conversely, in vitro methylation of the enhancer sequences abolished their activity. The results suggest that methylation of control regions in the EBV genome may play a critical role for the regulation of viral gene expression in tumor cells.

PubMed Disclaimer

Cited by

Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation.
Tierney RJ, Kirby HE, Nagra JK, Desmond J, Bell AI, Rickinson AB. Tierney RJ, et al. J Virol. 2000 Nov;74(22):10468-79. doi: 10.1128/jvi.74.22.10468-10479.2000. J Virol. 2000. PMID: 11044091 Free PMC article.
Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals.
Paulson EJ, Speck SH. Paulson EJ, et al. J Virol. 1999 Dec;73(12):9959-68. doi: 10.1128/JVI.73.12.9959-9968.1999. J Virol. 1999. PMID: 10559309 Free PMC article.
Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.
Schaefer BC, Strominger JL, Speck SH. Schaefer BC, et al. Mol Cell Biol. 1997 Jan;17(1):364-77. doi: 10.1128/MCB.17.1.364. Mol Cell Biol. 1997. PMID: 8972217 Free PMC article.
Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.
Hughes DJ, Marendy EM, Dickerson CA, Yetming KD, Sample CE, Sample JT. Hughes DJ, et al. J Virol. 2012 Jan;86(2):1034-45. doi: 10.1128/JVI.05923-11. Epub 2011 Nov 9. J Virol. 2012. PMID: 22072770 Free PMC article.

References

1. J Virol. 1987 Nov;61(11):3424-30 - PubMed
1. J Exp Med. 1988 Jun 1;167(6):1811-24 - PubMed
1. Int J Cancer. 1985 Apr 15;35(4):435-41 - PubMed
1. Nucleic Acids Res. 1986 Sep 11;14(17):7103-14 - PubMed
1. Mol Cell Biol. 1988 Feb;8(2):930-7 - PubMed

Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines - PubMed